Try our beta test site
24 studies found for:    stem cells AND lupus
Show Display Options
Rank Status Study
1 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
2 Withdrawn Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic Stem Cell Transplantation
3 Active, not recruiting Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Hematopoietic stem cell transplantation
4 Completed Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Immune ablation and hematopoietic stem cell support.
5 Recruiting Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: Immunoablation and Autologous Hematopoietic Stem Cell Transplantation
6 Not yet recruiting MsciSLE: MSCs in SLE Trial
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Low Dose Mesenchymal Stem Cells (MSCs);   Drug: High Dose Mesenchymal Stem Cells (MSCs);   Drug: Placebo Infusion
7 Completed
Has Results
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Biological: Rituxan (rituximab);   Biological: filgrastim;   Drug: methylprednisolone;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Diphenhydramine;   Drug: Mesna
8 Unknown  Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
9 Unknown  Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Human Umbilical Cord derived MSCs;   Drug: Cyclophosphamide
10 Unknown  Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: human umbilical cord derived MSC transplantation for SLE
11 Terminated Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
Conditions: Systemic Lupus Erythematosus;   Rheumatoid Arthritis;   Sharp's Syndrome
Interventions: Other: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs;   Other: Lipoaspiration
12 Unknown  Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
13 Terminated Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus;   Systemic Sclerosis
Intervention: Procedure: Nonmyeloablative allogeneic stem cell transplant
14 Withdrawn Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
Condition: Systemic Lupus Erythematosus
Interventions: Procedure: Leukapheresis;   Procedure: Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT);   Procedure: Autologous CD34+HPC transplantation (HSCT);   Procedure: Plasmapheresis;   Drug: Rabbit anti-thymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Drug: Corticosteroids;   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Intravenous immunoglobulin;   Drug: Methotrexate;   Drug: Rituximab;   Drug: Leflunomide
15 Unknown  Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: filgrastim;   Procedure: CD34+ Peripheral Blood Stem Cell Reinfusion
16 Unknown  Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Supervised physical exercise
17 Terminated
Has Results
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
Conditions: Systemic Lupus Erythematosus;   Systemic Sclerosis
Interventions: Procedure: Reduced Intensity Allogeneic Transplant;   Drug: Fludarabine;   Drug: Busulfan;   Drug: Campath
18 Terminated Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Interventions: Biological: Autologous Stem Cell Transplant;   Biological: Allogeneic Stem Cell Transplant
19 Completed Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Conditions: Systemic Sclerosis;   Systemic Lupus Erythematosus;   Dermatomyositis;   Juvenile Rheumatoid Arthritis;   Autoimmune Diseases
Interventions: Procedure: Stem Cell Transplantation;   Device: CD34 selection
20 Unknown  Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.